Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1998JAMA

Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRoy M. GulickCornell UniversityJMJohn W. MellorsRutgers, The State University of New JerseyDHDiane V. HavlirUniversity of California, San Francisco

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gulick et al. (1998) studied this question.

synapsesocial.com/papers/6a08c2ac5686deba6901e97chttps://doi.org/10.1001/jama.280.1.35
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients1996 · 179 citations
  2. 2Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy1997 · 27 citations
  3. 3Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor1996 · 406 citations
  4. 4Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy1998 · 211 citations
  5. 5The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir1998 · 224 citations